CC BY
27
Investigation of Cyclobenzaprine Interactions with P450 Cytochromes CYP1A2 and CYp3a4 through Molecular Docking Tools
Douglas Vieira Thomaz 1, Edson Silvio Batista Rodrigues 1, Fabio Bahls Machado 1,
Isaac Yves Lopes de Macedo 1
1 Universidade Federal de Goias
240 street, Leste Universitario district, Goiania - GO, 74605-170, Brazil
DOI: 10.22178/pos.43-1
LCC Subject Category: RM1-950
Received 20.01.2019 Accepted 20.02.2019 Published online 28.02.2019
Corresponding Author:
Douglas Vieira Thomaz [email protected]
© 2019 The Authors. This article is licensed under a Creative Commons Attribution 4.0 License L©-iL-1
Abstract. Cyclobenzaprine (CBP) is a centrally acting muscle relaxant whose myriad of therapeutic applications imply the need of better understanding its pharmacokinetics and thermodynamics. Henceforth, this work was concerned with an in silico investigation of CBP main metabolizers in the human organism, namely CYP1A2 and CYP3A4. For this purpose, computational methods were employed, such as molecular docking and other semi-empirical approaches. Results evidenced that the model herein depicted for CBP-CYP1A2 may not reproducibly represent the physiological interaction between CBP and this enzyme. Moreover, CBP-CYP3A4 docking results evidence thermodynamic feasibility of the molecular docking model and were further corroborated by literature, what may reproducibly represent a possible interaction between CBP and this macromolecule.
Keywords: tricyclic; cheminformatics; redox enzymes; metabolism; pharmacokinesis.
INTRODUCTION
Cyclobenzaprine (CBP) is a centrally acting muscle relaxant whose applicability range from treating acute musculoskeletal pain to chronic conditions such as fibromyalgia. The structure of this compound is quite similar to that of tricyclic antidepressants, which implies the possibility of yet unknown therapeutic uses. Albeit CBP metabolism has been studied under the light of different methods over the years, the thermodynamics and kinetics of its molecular docking interactions in the context of xenobiotic metabolism are yet unknown [4, 5, 22, 24].
CBP metabolism is primarily mediated by P450-family cytochromes (CYP), more specifically CYP1A2 and CYP3A4, what implies that the association of this muscle relaxant with other drugs primarily metabolized by these CYP isoforms might result in important interactions, which could henceforth affect patient safety. Although the enzymes responsible for CBP metabolism have been identified, there were, to the best of our knowledge, no studies regarding the thermodynamics of CBP-CYP interaction [17, 19, 20, 23].
Regarding molecular docking strategies, programs such as AutoDock Vina allows fast scoring function set up as well as quick calculations, what is optimal in preliminary screenings for pharma-codynamical prediction as well as medicinal chemistry studies. Furthermore, the concomitant employment of semi-empirical approaches to minimize the energy of complex chemical compounds, further increase the appeal of computational chemistry in investigations concerning drug-receptor interactions [1, 6, 7].
In view of the importance of better understanding CBP metabolism as well as the thermodynamics of its docking with the major metaboliz-ers (CYP1A2 and CYP3A4), this work is intended to employ cheminformatics tools to establish a semi-flexible docking model of CBP-CYP interaction. Henceforth, CBP structure had its energy minimized through molecular mechanic functions and was subjected to docking studies as a flexible ligand to interact with a rigid macromolecule i.e. CYP.
METHODS
CBP (dimethyl(3-{tricydo[9A0.03,8]pentadeca-
1(15),3,5,7,9,11,13-heptaen-2-ylidene}propyl)amine) structure was minimized through Chimera software version 1.13 coupled to Molecular Modeling Toolkit (MMTK) and AMBER toolkit 4.0 prior docking studies. The same software was used to edit protein units retrieved from Protein DataBank (PDB). Moreover, the software Phyton Molecular Viewer (PMV) version 1.5.6 was used to evaluate torsion-prone regions in CBP molecule, and the docking models were conducted using AutoDock Vina and AutoDock Tools version 1.5.6. The docking model herein employed is based on a flexible ligand and a rigid receptor, therefore configuring itself in a semi-flexible model [2, 16, 18]. The minimization in energy conformation and HOMO surface calculations were performed employing the MM2 Force Field in Chem-Draw3D®Pro 12.
CYP1A2 (PDB entry: 2HI4) and CYP3A4 (PDB entry: 4NY4) were used in this study.
Concerning intermolecular thermodynamics, Gibbs free energy values correlate to the maximum of reversible work feasible at a given system. In this context, it can be related to the inter-
action proneness between two molecules in a docking model. This parameter can be calculated through the following equation (1):
AG = RT ln K, (1)
where AG is the interaction affinity; R is the gas constant and T is the temperature.
The equation (1) can be derived into order to yield the interaction constant K .
AG
K = eRT , (2)
where e is the Euler's number.
RESULTS AND DISCUSSION
In order to prepare CBP molecule for docking, CBP energy was minimized henceforth rendering the lowest energy conformer. Moreover, the highest occupied molecular orbital (HOMO) regions were also calculated as well as the torsion-feasible regions. Results are displayed in Figure 1.
Figure 1 - Results of CBP energy minimization
Notes: A) Chemical structure of CBP lowest energy conformer evidencing a vinylic bridge (Vin) and the terminal aliphatic chain (AC). B) HOMO depictions of CBP lowest energy conformer depicting low (Blue) and high (Red) electron density regions. AC region correlates to HOMO-1 whereas Vin correlates to HOMO.
All data gathered through Chimera software version 1.13.
Results evidenced that CBP lowest energy con-former tricyclic ring does display a slight distortion in the vinyl moiety (Vin) towards the same plane of the terminal aliphatic chain (AC), which grants the molecule a bent shape (Figure 1A). Moreover, HOMO regions of the molecule evidence that there are two sites of elevated electron density in CBP, namely the Vin moiety and the tri-substituted amine in the AC. Further analysis evidenced that these moieties correlate to HOMO-1 and HOMO in Vin and AC, respectively (Figure 1B). Concerning torsion-prone re-
gions, CBP AC is the sole moiety capable of rotation hence it is based on asp3-sP3 covalent bonds.
A molecular docking study was undergone to analyze CBP interaction with CYP1A2. Henceforth the gridline for the docking study was set around the protoporphyrin ring of CYP1A2 molecule employing high exhaustiveness, which was set to 20. Figure 2 displays the highest scoring model with the distances between CBP, nearby residues and the iron moiety in the protoporphyrin ring system measured in angstroms (A).
Figure 2 - Docking depiction of the highest scoring model for CBP-CYP1A2 interaction
Notes: NDistances therein highlighted between CBP molecule (Blue) and nearby residues as well as to the iron moiety of the protoporphiric group (orange sphere). All data gathered through Chimera software version 1.13.
CBP highest scoring docking models presented no hydrogen bonds, albeit dipole interactions were seen (Figure 2A), which is a common occurrence in docking models [8, 9, 10]. However, the distance between CBP and the iron moiety in the protoporphyrin ring is nonetheless too distant to seemingly promote catalysis (19.5 A). In this context, the model herein presented for CBP-CYP1A2 interaction may not be able to efficiently correlate itself with experimental data reported in the literature [11, 12, 15, 25].
Although some models scored below the best presented additional hydrogen bonds, which are usually responsible for thermodynamic stable interactions between molecules, non-specific dipole interactions; molecular packaging and steric hindrance may generate false positives in docking models [3, 13, 14, 21]. Given that the prosthetic group of the macromolecule herein concerned is intimately involved in reactional steps, the model; although thermodynamic feasible, may not be reproducible [12, 15].
CBP interactions with CYP3A4 were also evaluated through a molecular docking. Henceforth the gridline for the docking study was again set around the protoporphyrin ring; this time; of the CYP3A4 molecule. Furthermore, exhaustiveness
was set to 20. Figure 3 displays the highest scoring model with the distances between CBP and the iron moiety in the protoporphyrin ring system measured in angstroms (A).
Figure 3 - Docking depiction of the highest scoring model for CBP-CYP3A4 interaction
Notes: Distances therein highlighted between CBP molecule (Blue) and the iron moiety of the protoporphiric group (orange sphere). All data gathered through Chimera software version 1.13.
Results evidenced that the highest scoring model presented optimal thermodynamic properties, and the distance between CBP and the iron moiety in the protoporphyrin ring system (9.0 A) was nonetheless inferior to the one observed in the model above-displayed for CBP-CYP1A2 interaction (Figure 3A and 3B).
Literature reports that CYP catalytic properties are attributed to the protoporphyrin ring which is chelated to an iron unit. This moiety is the main prosthetic group of P450 enzymes, and the condensed pyrrole aromatic nuclei associated to the transition metal; which is itself a lewis acid; enhances henceforth the redox capabilities of these catalytic biomolecules. This effect is caused by the dislodgement of electrons from the ligand towards CYP-prosthetic group, what nonetheless further justifies the model herein depicted since
the interacting molecule should be in close proximity to the prosthetic group for this process to happen [12, 15].
Equations (1) and (2) cited in the methods section were employed to calculate K of the highest ranking docking models for CBP interaction with CYP1A2 and CYP3A4. Results are displayed in Table 1.
Results evidenced that Ki for CYP1A2 macromolecule interaction with CBP was higher than that of CBP-CYP3A4 interaction. However, the calculated values were fairly similar, having low differentiability. Nonetheless, the number of dipole interactions exhibited by CBP-CYP1A2 might justify the higher constant value, although this model may not reproducibly represent the interaction between these molecules.
Table 1 - Thermodynamic properties calculated for the lowest energy conformation in the docking of CBP-CYP1A2 and CBP-CYP3A4
Receptor Affinity (kcal.mol"1) Binding Constant (cal.mol-1.K-1) RMSD l.b. RMSB u.b. HBonds (ligand) HBonds (receptor)
CYP1A2 -8.0 0.9866 0.0 0.0 0 0
CYP3A4 -8.8 0.9853 0.0 0.0 0 0
CONCLUSION
This work presented a study regarding CBP interaction with CYP1A2 and CYP3A4. Results evidenced that the model herein depicted for CBP-CYP1A2 may not reproducibly represent the physiological interaction between CBP and this
enzyme. Moreover, CBP-CYP3A4 results from evidence thermodynamical feasibility of the molecular docking model and were further corroborated by literature, what may reproducibly represent a possible interaction between CBP and this macromolecule.
REFERENCES
1. Amaro, R. E., Baudry, J., Chodera, J., Demir, 0., McCammon, J. A., Miao, Y., & Smith, J. C. (2018).
Ensemble Docking in Drug Discovery. Biophysical Journal, 114(10), 2271-2278. doi: 10.1016/j.bpj.2018.02.038
2. Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., ... Woods, R. J. (2005). The
Amber biomolecular simulation programs. Journal of Computational Chemistry, 26(16), 16681688. doi: 10.1002/jcc.20290
3. Cosconati, S., Forli, S., Perryman, A. L., Harris, R., Goodsell, D. S., & Olson, A. J. (2010). Virtual screening
with AutoDock: theory and practice. Expert Opinion on Drug Discovery, 5(6), 597-607. doi: 10.1517/17460441.2010.484460
4. Darwish, H. W., Naguib, I. A., & Darwish, I. A. (2018). Five modified classical least squares based
models for stability indicating analysis of cyclobenzaprine HCl with its major degradation products: A comparative study. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 204, 598-602. doi: 10.1016/j.saa.2018.06.101
5. De Santana Santos, T., Calazans, A. C. M., Martins-Filho, P. R. S., Silva, L. C. F. da, de Oliveira e Silva, E.
D., & Gomes, A. C. A. (2011). Evaluation of the muscle relaxant cyclobenzaprine after third-molar extraction. The Journal of the American Dental Association, 142(10), 1154-1162. doi: 10.14219/jada.archive.2011.0084
6. Garcia-Nieto, J., Lopez-Camacho, E., Garcia-Godoy, M. J., Nebro, A. J., & Aldana-Montes, J. F. (2019).
Multi-objective ligand-protein docking with particle swarm optimizers. Swarm and Evolutionary Computation, 44, 439-452. doi: 10.1016/j.swevo.2018.05.007
7. Gupta, M., Sharma, R., & Kumar, A. (2018). Docking techniques in pharmacology: How much
promising? Computational Biology and Chemistry, 76, 210-217. doi: 10.1016/j.compbiolchem.2018.06.005
8. Jiang, X., Tsona, N. T., Tang, S., & Du, L. (2018). Hydrogen bond docking preference in furans: O H — n
vs. O H — O. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 191, 155-164. doi: 10.1016/j.saa.2017.10.006
9. Khorasani, R., & Fleming, P. E. (2016). On calculating HR bond enthalpies using computational data.
Computational and Theoretical Chemistry, 1096, 89-93. doi: 10.1016/j.comptc.2016.09.033
10. Kumar, S. P. (2018). PLHINT: A knowledge-driven computational approach based on the
intermolecular H bond interactions at the protein-ligand interface from docking solutions. Journal of Molecular Graphics and Modelling, 79, 194-212. doi: 10.1016/j.jmgm.2017.12.002
11. Lynch, D. E., & Reeves, C. R. (2019). Statistical analysis of the effect of a single O H hydrogen-
bonding interaction on carbonyl bond lengths. Journal of Molecular Structure, 1180, 158-162. doi: 10.1016/j.molstruc.2018.11.100
12. Mena-Ulecia, K., & MacLeod-Carey, D. (2018). Interactions of 2-phenyl-benzotriazole xenobiotic
compounds with human Cytochrome P450-CYP1A1 by means of docking, molecular dynamics simulations and MM-GBSA calculations. Computational Biology and Chemistry, 74, 253-262. doi: 10.1016/j.compbiolchem.2018.04.004
13. Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011). Molecular Docking: A Powerful Approach for
Structure-Based Drug Discovery. Current Computer Aided-Drug Design, 7(2), 146-157. doi: 10.2174/157340911795677602
14. Morris, G. M., & Lim-Wilby, M. (2008). Molecular Docking. Molecular Modeling of Proteins, 365-382.
doi: 10.1007/978-1-59745-177-2_19
15. Ramesh, M., & Bharatam, P. V. (2014). Importance of hydrophobic parameters in identifying
appropriate pose of CYP substrates in cytochromes. European Journal of Medicinal Chemistry, 71, 15-23. doi: 10.1016/j.ejmech.2013.10.023
16. Salomon-Ferrer, R., Case, D. A., & Walker, R. C. (2012). An overview of the Amber biomolecular
simulation package. Wiley Interdisciplinary Reviews: Computational Molecular Science, 3(2), 198210. doi: 10.1002/wcms.1121
17. Share, N. N., & McFarlane, C. S. (1975). Cyclobenzaprine: A novel centrally acting skeletal muscle
relaxant. Neuropharmacology, 14(9), 675-684. doi: 10.1016/0028-3908(75)90091-x
18. Trott, O., & Olson, A. J. (2009). AutoDock Vina: Improving the speed and accuracy of docking with a
new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, NA-NA. doi: 10.1002/jcc.21334
19. Wang, R. W., Liu, L., Cheng, H. (1996). Identification of human liver cytochrome P450 isoforms
involved in the in vitro metabolism of cyclobenzaprine. Drug Metabolism and Disposition, 24(7), 786-791.
20. Winchell, G. A., King, J. D., Chavez-Eng, C. M., Constanzer, M. L., & Korn, S. H. (2002). Cyclobenzaprine
pharmacokinetics, including the effects of age, gender, and hepatic insufficiency. The Journal of Clinical Pharmacology, 42(1), 61-69.
21. Wu, M.-Y., Dai, D.-Q., & Yan, H. (2012). PRL-dock: Protein-ligand docking based on hydrogen bond
matching and probabilistic relaxation labeling. Proteins: Structure, Function, and Bioinformatics, 80(9), 2137-2153. doi: 10.1002/prot.24104
22. Yang, Y. W., Macdonald, J. B., Nelson, S. A., & Sekulic, A. (2017). Treatment of vismodegib-associated
muscle cramps with cyclobenzaprine: A retrospective review. Journal of the American Academy of Dermatology, 77(6), 1170-1172. doi: 10.1016/j.jaad.2016.12.017
23. Zhang, D., Evans, F. E., Freeman, J. P., Yang, Y., Deck, J., & Cerniglia, C. E. (1996). Formation of
mammalian metabolites of cyclobenzaprine by the fungus, Cunninghamella elegans. Chemico-Biological Interactions, 102(2), 79-92. doi: 10.1016/s0009-2797(96)03736-2
24. Zhang, T.-T., Xue, R., Wang, X., Zhao, S.-W., An, L., Li, Y.-F., ... Li, S. (2018). Network-based drug
repositioning: A novel strategy for discovering potential antidepressants and their mode of action. European Neuropsychopharmacology, 28(10), 1137-1150. doi: 10.1016/j.euroneuro.2018.07.096
25. Zhao, H., Tang, S., & Du, L. (2017). Hydrogen bond docking site competition in methyl esters.
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 181, 122-130. doi: 10.1016/j.saa.2017.03.038
